Search clinical trials for: Oxaliplatin IV

Total 4984 results

argenx

Completed

Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis (ADAPTsc)

Generalized Myasthenia Gravis

Spain, United States, Belgium, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation
Ralph Beltran

Completed

Prospective Observational Study of Difficult Intravenous Access in the Operating Room

Difficult Intravenous Access

United States
Coopervision, Inc.

Completed

Clinical Performance of Habitual Wearers of Bioclear 1-day Lenses When Refitted With Biomedics 1-day Extra for 1 Week

Myopia | Hyperopia

Spain
Centre Hospitalier Universitaire, Amiens

Completed

Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction (DYSPRED)

Shock, Septic | Ventricular Dysfunction, Left

France
Singapore General Hospital
Singapore Civil Defence Force

Completed

Intraosseous vs Intravenous Access for Cardiac Arrest Treatment

Cardiac Arrest

Singapore
MedImmune LLC

Completed

To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease

Coronary Artery Disease

United States
University of Tennessee Medical Center

Completed

HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients

Septic Shock

United States
Nang Kuang Pharmaceutical Co., Ltd.

Terminated

Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer

Neoplasms, Head and Neck | Cancer of the Head and Neck

Taiwan
Sanofi

Completed

Oxaliplatin in Unresectable Hepatocellular Carcinoma

Carcinoma, Hepatocellular
University of Massachusetts, Worcester

Completed

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

Colorectal Cancer | Peritoneal Carcinomatosis | Appendix Cancer

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

Colorectal Cancer

United States
LiNing

Not yet recruiting

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Stomach Neoplasms

China
Naurex, Inc, an affiliate of Allergan plc

Terminated

Open Label Extension for GLYX13-C-202, NCT01684163

Major Depressive Disorder

United States
Wuhan Union Hospital, China

Recruiting

Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC

Advanced Gastric Cancer | Advanced Gastroesophageal Junction Adenocarcinoma

China
Jordi Gol i Gurina Foundation

Completed

Long-Term Survival After Ischaemic Stroke: Ebrictus Study (EBRICTUS)

Ischemic Stroke | Long Term Adverse Effects | Gender Bias | Thrombolytic (t-PA) Treatment

Spain
Sanofi

Completed

Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma

Gastric Cancer

Korea, Republic of
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction

Esophageal Cancer | Adenocarcinoma of the Gastroesophageal Junction

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia

Endocrine Tumors | Colon Tumors | Rectum Tumors | Appendix Tumors | Peritoneum Tumors

France
Albert Einstein College of Medicine
Sanofi

Completed

Exploratory Study Of The ERCC-1 Gene

Rectal Cancer | Colon Cancer

United States
Eli Lilly and Company

Recruiting

A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Alzheimer's Disease

United States, Japan
Amgen

Active, not recruiting

Myasthenia Gravis Inebilizumab Trial (MINT)

Myasthenia Gravis

United States, Argentina, Belarus, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
Healeon Medical Inc
Terry, Glenn C., M.D.

Enrolling by invitation

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (ADcSVF-IBD)

Inflammatory Bowel Diseases

United States
Healeon Medical Inc

Withdrawn

Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia (ADcSVF-CRPS)

Fibromyalgia | RSD (Reflex Sympathetic Dystrophy) | CRPS - Complex Regional Pain Syndrome Type I

United States, Honduras
Eli Lilly and Company

Completed

A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants

Healthy

Singapore
Pediatrix
Banner Health

Terminated

Hydrotherapy for the Reversal of Oligohydramnios (STRONG)

Oligohydramnios

United States
Eli Lilly and Company

Completed

A Study of LY2541546 in Healthy Postmenopausal Women

Healthy

United States
Stanford University

Completed

Study of Heat and Intravenous Fluids for Exogenous Rewarming (SHIVER)

Hypothermia
Seoul National University Hospital

Completed

Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study

Gastroesophageal Reflux Disease

Korea, Republic of
Mallinckrodt

Completed

Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain

Pain

United States
Peking University Cancer Hospital & Institute
Peking University People's Hospital; Peking Union Medical College Hospital

Recruiting

Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) (EPAC1)

Adjuvant Chemotherapy

China
Royal Marsden NHS Foundation Trust

Completed

A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer

Rectal Cancer
Chengdu University of Traditional Chinese Medicine

Not yet recruiting

Cohort Study of Auricular Acupressure for Postoperative Pain After Hemorrhoidectiomy

Postoperative Pain After Hemorrhoidectomy
Greet Van den Berghe

Active, not recruiting

Tight Glycemic Control With Intensive Insulin Therapy in PICU

Critical Illness

Belgium
Cytokinetics

Completed

PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina

Myocardial Ischemia | Heart Failure | Angina Pectoris

Georgia, Russian Federation
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG

Terminated

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

Colorectal Cancer | Liver Metastases

Netherlands
AstraZeneca

Completed

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Healthy Elderly | Mild-Moderate Alzheimer's Disease

United States
Shanghai Zhongshan Hospital

Unknown

Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma

China
University Hospital, Montpellier
Federation Francophone de Cancerologie Digestive

Recruiting

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma (GEMOXIA-02)

Cholangiocarcinoma Non-resectable | Non-metastatic

France
UNICANCER

Completed

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Colorectal Cancer

France
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon-Plus)

Docetaxel, Oxaliplatin and Fluorouracil

China
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Center, Korea

Completed

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer (TIROX2)

Stomach Neoplasms

Korea, Republic of
National Cancer Center, Korea

Unknown

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy (TIROX)

Colorectal Neoplasm | Secondary | Gastric Neoplasm

Korea, Republic of
Zhejiang University

Recruiting

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

Liver Metastases

China
Asan Medical Center

Recruiting

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

Stomach Neoplasm

Korea, Republic of
Cancer Research UK

Completed

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Colorectal Cancer

United Kingdom
Roswell Park Cancer Institute

Completed

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

Colorectal Cancer

United States
University of Chicago
National Cancer Institute (NCI)

Completed

Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer

Lung Cancer

United States

Search clinical trials for: Oxaliplatin IV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations